GLP-1 Shipment Arrived Warm: What to Check Before Using It

If your injectable GLP-1 medication arrives warm or with insufficient refrigeration, do not use it while you investigate. FDA specifically recommends against using an injectable GLP-1 drug received under those conditions because its quality may be affected. The warning follows complaints involving warm compounded products and inadequate ice packs.¹ Contact the dispensing pharmacy promptly and document the delivery.

A melted ice pack alone cannot give you the medicine's complete temperature history. Neither can a photograph or a hand against the box. Your job is to preserve the facts and obtain a product-specific answer, not to prove the medication is usable. This checklist was checked against public sources on October 6, 2026; it cannot assess your shipment remotely.

Open, document and keep the product identifiable

Record the carrier's delivery time, when you brought the package inside and when you opened it. Photograph the outer box, shipping label, insulation, ice packs, medication packaging and any temperature indicator. Save the tracking history, especially a delay or a delivery exception. Record what you observed without guessing an exact temperature you did not measure.

Keep the prescription number, drug name, pharmacy, lot number and expiration or beyond-use date available. Do not remove identifying labels or combine the shipment with an older supply. Keep the medication separate from stock you are using, retain its packaging, and follow its labeled storage directions while awaiting advice. If those directions are missing or unclear, ask the pharmacy immediately how to hold it pending investigation.

There is no need to post photographs of your prescription publicly. Use the pharmacy's secure channel and keep a copy for yourself. The evidence should make it possible to trace this particular order rather than produce a debate about how warm someone else's package felt.

Start with the dispensing pharmacist

The telehealth company's billing desk may arrange a replacement, but the product question belongs with the dispensing pharmacy. Ask to speak with a pharmacist and provide the delivery record. Useful questions are: What storage instructions apply to this exact formulation and container? What temperature information is available for this shipment? What should I do with it while the problem is assessed? Will you replace it, and who will coordinate that?

If someone replies that the medicine “can be warm,” request an explanation specific to the dispensed product and the reported conditions. Ask how that answer addresses FDA's shipping warning. A general stability statement is not a documented temperature record for your box. Do not take a customer-service reassurance as permission to disregard the warning.

If the pharmacy details do not match the seller’s information, verify the pharmacy independently before relying on a reply from an unfamiliar contact.

Keep the case number, the person's role and the written response. If the pharmacy and seller give conflicting answers, send the conflict back to the pharmacist and prescribing clinician before using the medication.

Brand-name allowances have exact boundaries

Approved products have their own labeled storage conditions. Those conditions can help a pharmacist assess a known exposure; they do not establish what happened during an unmonitored delivery. Identify the exact brand and device before looking up an allowance. Different presentations of the same brand can have different instructions.

For example, the current U.S. instructions for the Wegovy single-dose injection pen specify refrigerated storage at 36°F–46°F (2°C–8°C). Before cap removal, that pen may be kept in its original carton at 46°F–86°F (8°C–30°C) for up to 28 days. The instructions also address discarding pens after freezing, excessive heat, light exposure or exceeding the allowed time. This example is specifically about that single-dose pen, not every Wegovy presentation.²

The current U.S. Zepbound instructions allow its single-dose pen and single-dose vial to be kept unrefrigerated at no more than 86°F (30°C) for a total of up to 21 days. They require protection from heat and light and prohibit freezing. That statement does not describe Zepbound's multidose presentations or KwikPen.³

These are boundaries, not a test you can run after delivery. A temperature measured when you open the box does not establish the maximum temperature earlier in transit. If the exposure is unknown, give that uncertainty to the pharmacist rather than filling it in with the room-temperature allowance.

Do not apply those numbers to a compounded vial

A vial labeled compounded semaglutide is not a Wegovy single-dose pen. Compounded tirzepatide is not a Zepbound single-dose vial. Ask the pharmacy about the formulation, container, lot and instructions it actually dispensed. Our vial-label guide helps you locate the relevant fields without turning them into dose calculations.

Pharmacy instructions can also vary by product and lot. Empower's 2026 storage update expressly tells patients with older lots to follow the storage directions on those labels and provides a clinical contact for product questions.⁴ This is a reason to retain your own paperwork, not to generalize that pharmacy's broad storage announcement to a GLP-1 shipment. For background on the distinction, see compounded versus brand-name medication.

Planning to carry your medication on a trip? Our travel guide covers the separate questions about paperwork, supply and storage arrangements before departure.

Resolve the replacement and the treatment timeline separately

Ask the seller who pays for replacement shipping, whether an expedited replacement is available, and whether it needs the original package retained or returned. Request its applicable replacement or refund policy and any reporting deadline. A product-quality concern and an entitlement to a refund are different questions; do not assume one automatically resolves the other.

If the delay affects your next scheduled treatment, tell your prescriber and request medication-specific instructions. Do not improvise a replacement dose or restart plan while waiting on a billing dispute. Keep the written resolution with your order records.

Before your next order, ask how the service handles delivery delays, temperature complaints and pharmacist access. Those answers belong in choosing a GLP-1 provider just as much as the monthly price. If the experience makes you leave, check the cancellation guide so reporting a bad shipment does not get mistaken for canceling future renewals.